CIM
VYGR icon

CIM Investment Management’s Voyager Therapeutics VYGR Stock Holding History

CIM Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,691
Closed -$73K – 329
2021
Q2 		$73K Hold
17,691
– – 0.02% 297
2021
Q1 		$83K Sell
17,691
-1,054
-6% -$7.19K 0.03% 297
2020
Q4 		$134K Hold
18,745
– – 0.04% 283
2020
Q3 		$200K Buy
+18,745
New +$220K 0.08% 238
2019
Q2 		– Sell
-10,156
Closed -$194K – 344
2019
Q1 		$194K Sell
10,156
-10,334
-50% -$135K 0.07% 301
2018
Q4 		$193K Hold
20,490
– – 0.08% 285
2018
Q3 		$388K Hold
20,490
– – 0.14% 213
2018
Q2 		$400K Buy
+20,490
New +$405K 0.14% 211

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIM Investment Management's VYGR Position: Q3 2021 in Review

CIM Investment Management sold out of Voyager Therapeutics (VYGR) in Q3 2021, closing a stake of 17,691 shares — an estimated $73K sold.

CIM Investment Management first reported a position in VYGR in Q2 2018 and held it in 8 quarters. The position peaked at $400K in Q2 2018. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2021.

  • CIM Investment Management reported no remaining Voyager Therapeutics position as of Q3 2021 after selling out during the quarter.
  • CIM Investment Management sold 17,691 Voyager Therapeutics shares in Q3 2021, an estimated $73K.
  • CIM Investment Management first reported a position in Voyager Therapeutics in Q2 2018 and held it in 8 quarters.
  • CIM Investment Management's Voyager Therapeutics position peaked at $400K in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2021.

Based on CIM Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.